These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27159879)

  • 1. Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems.
    Wang X; Wang N; Li N; Zhen Y; Wang T
    Hum Vaccin Immunother; 2016 Aug; 12(8):2075-2089. PubMed ID: 27159879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant-dual delivery system (VADDS).
    Wang N; Zhen Y; Jin Y; Wang X; Li N; Jiang S; Wang T
    J Control Release; 2017 Jan; 246():12-29. PubMed ID: 27986552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses.
    Li N; Wang N; Wang X; Zhen Y; Wang T
    Drug Deliv; 2016 Nov; 23(9):3234-3247. PubMed ID: 26967666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of the Multifunctional Liposome-Containing Microneedle Arrays as an Oral Cavity Mucosal Vaccine Adjuvant-Delivery System.
    Wang T; Wang N
    Methods Mol Biol; 2016; 1404():651-667. PubMed ID: 27076328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems.
    Wang N; Qian R; Liu T; Wu T; Wang T
    Crit Rev Ther Drug Carrier Syst; 2019; 36(5):449-484. PubMed ID: 32421952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination.
    Zhen Y; Wang N; Gao Z; Ma X; Wei B; Deng Y; Wang T
    Vaccine; 2015 Aug; 33(35):4330-40. PubMed ID: 25858854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
    Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
    Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier.
    Saeed MI; Omar AR; Hussein MZ; Elkhidir IM; Sekawi Z
    Hum Vaccin Immunother; 2015; 11(10):2414-24. PubMed ID: 26186664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
    Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
    Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.